CLCN7, a gene shared by autosomal recessive and autosomal dominant osteopetrosis.

Bone Pub Date : 2022-12-01 DOI:10.2139/ssrn.4207532
T. Stauber, Lena Wartosch, Svenja Vishnolia, A. Schulz, U. Kornak
{"title":"CLCN7, a gene shared by autosomal recessive and autosomal dominant osteopetrosis.","authors":"T. Stauber, Lena Wartosch, Svenja Vishnolia, A. Schulz, U. Kornak","doi":"10.2139/ssrn.4207532","DOIUrl":null,"url":null,"abstract":"After the discovery of abundant v-ATPase complexes in the osteoclast ruffled membrane it was obvious that in parallel a negative counter-ion needs to be transported across this membrane to allow for efficient transport of protons into the resorption lacuna. While different candidate proteins were discussed the osteopetrosis phenotype of Clcn7 knockout mice suggested that the chloride/proton-exchanger ClC-7 might be responsible for transporting the negative charge. In the following, individuals with autosomal recessive osteopetrosis (ARO) were found to carry biallelic CLCN7 pathogenic variants. Shortly thereafter, heterozygous pathogenic variants were identified as the exclusive cause of autosomal dominant osteopetrosis type 2 (ADO2). Since in most cell types other than osteoclasts ClC-7 resides in late endosomes and lysosomes, it took some time until the electrophysiological properties of ClC-7 were elucidated. Whereas most missense variants lead to reduced chloride currents, several variants with accelerated kinetics have been identified. Evidence for folding problems is also known for several missense variants. Paradoxically, a heterozygous activating variant in ClC-7 was described to cause lysosomal alteration, pigmentation defects, and intellectual disability without osteopetrosis. The counter-intuitive 2 Cl-/H+ exchange function of ClC-7 was shown to be physiologically important for intravesicular ion homeostasis. The lysosomal function of ClC-7 is also the reason why individuals with CLCN7-ARO can develop a storage disorder and neurodegeneration, a feature that is variable and difficult to predict. Furthermore, the low penetrance of heterozygous pathogenic CLCN7 variants and the clinical variability of ADO2 are incompletely understood. We aim to give an overview not only of the current knowledge about ClC-7 and its related pathologies, but also of the scientists and clinicians that paved the way for these discoveries.","PeriodicalId":93913,"journal":{"name":"Bone","volume":"1 1","pages":"116639"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone","FirstCategoryId":"0","ListUrlMain":"https://doi.org/10.2139/ssrn.4207532","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

After the discovery of abundant v-ATPase complexes in the osteoclast ruffled membrane it was obvious that in parallel a negative counter-ion needs to be transported across this membrane to allow for efficient transport of protons into the resorption lacuna. While different candidate proteins were discussed the osteopetrosis phenotype of Clcn7 knockout mice suggested that the chloride/proton-exchanger ClC-7 might be responsible for transporting the negative charge. In the following, individuals with autosomal recessive osteopetrosis (ARO) were found to carry biallelic CLCN7 pathogenic variants. Shortly thereafter, heterozygous pathogenic variants were identified as the exclusive cause of autosomal dominant osteopetrosis type 2 (ADO2). Since in most cell types other than osteoclasts ClC-7 resides in late endosomes and lysosomes, it took some time until the electrophysiological properties of ClC-7 were elucidated. Whereas most missense variants lead to reduced chloride currents, several variants with accelerated kinetics have been identified. Evidence for folding problems is also known for several missense variants. Paradoxically, a heterozygous activating variant in ClC-7 was described to cause lysosomal alteration, pigmentation defects, and intellectual disability without osteopetrosis. The counter-intuitive 2 Cl-/H+ exchange function of ClC-7 was shown to be physiologically important for intravesicular ion homeostasis. The lysosomal function of ClC-7 is also the reason why individuals with CLCN7-ARO can develop a storage disorder and neurodegeneration, a feature that is variable and difficult to predict. Furthermore, the low penetrance of heterozygous pathogenic CLCN7 variants and the clinical variability of ADO2 are incompletely understood. We aim to give an overview not only of the current knowledge about ClC-7 and its related pathologies, but also of the scientists and clinicians that paved the way for these discoveries.
CLCN7,一种常染色体隐性遗传和常染色体显性遗传的骨质疏松症共有的基因。
在破骨细胞褶皱膜中发现丰富的v-ATP酶复合物后,很明显,需要平行地将负反离子输送穿过该膜,以允许质子有效地输送到吸收陷窝中。虽然讨论了不同的候选蛋白,但Clcn7敲除小鼠的骨质硬化表型表明氯化物/质子交换剂ClC-7可能负责转运负电荷。在下文中,发现常染色体隐性遗传性骨质疏松症(ARO)患者携带双等位基因CLCN7致病性变体。此后不久,杂合致病性变异被确定为常染色体显性遗传的2型骨质疏松症(ADO2)的唯一原因。由于在除破骨细胞外的大多数细胞类型中,ClC-7存在于晚期内体和溶酶体中,因此需要一段时间才能阐明ClC-7的电生理特性。尽管大多数错义变体会导致氯电流减少,但已经发现了几种具有加速动力学的变体。折叠问题的证据也是已知的几种错义变体。矛盾的是,ClC-7中的一种杂合激活变体被描述为导致溶酶体改变、色素沉着缺陷和智力残疾,而没有骨质疏松症。ClC-7的反直觉2 Cl-/H+交换功能对管内离子稳态具有重要的生理学意义。ClC-7的溶酶体功能也是CLCN7-ARO患者可能出现储存障碍和神经退行性变的原因,这是一个可变且难以预测的特征。此外,杂合致病性CLCN7变异体的低外显率和ADO2的临床变异性尚不完全清楚。我们的目的不仅是概述目前关于ClC-7及其相关病理学的知识,还概述为这些发现铺平道路的科学家和临床医生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信